Abstract

Psoraleae Fructus (PF) is a widely-used herb with diverse pharmacological activities, while its related hepatic injuries have aroused public concerns. In this work, a systematic approach based on RNA sequencing (RNA-seq), high-content screening (HCS) and molecular docking was developed to investigate the potential mechanism and identify major phytochemicals contributed to PF-induced hepatotoxicity. Animal experiments proved oral administration of PF water extracts disturbed lipid metabolism and promoted hepatic injuries by suppressing fatty acid and cholesterol catabolism. RNA-seq combined with KEGG enrichment analysis identified mitochondrial oxidative phosphorylation (OXPHOS) as the potential key pathway. Further experiments validated PF caused mitochondrial structure damage, mtDNA depletion and inhibited expressions of genes engaged in OXPHOS. By detecting mitochondrial membrane potential and mitochondrial superoxide, HCS identified bavachin, isobavachalcone, bakuchiol and psoralidin as most potent mitotoxic compounds in PF. Moreover, molecular docking confirmed the potential binding patterns and strong binding affinity of the critical compounds with mitochondrial respiratory complex. This study unveiled the underlying mechanism and phytochemicals in PF-induced liver injuries from the view of mitochondrial dysfunction.

Details

Title
Exploring the mechanism and phytochemicals in Psoraleae Fructus-induced hepatotoxicity based on RNA-seq, in vitro screening and molecular docking
Author
Shang, Huiying 1 ; Liu, Xian 2 ; Pan, Jinchao 3 ; Cheng, Hongbo 4 ; Ma, Zengchun 2 ; Xiao, Chengrong 2 ; Gao, Yue 2 

 Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China (GRID:grid.410648.f) (ISNI:0000 0001 1816 6218); Beijing Institute of Radiation Medicine, Department of Pharmaceutical Sciences, Beijing, People’s Republic of China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839) 
 Beijing Institute of Radiation Medicine, Department of Pharmaceutical Sciences, Beijing, People’s Republic of China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839) 
 Beijing Institute of Radiation Medicine, Department of Pharmaceutical Sciences, Beijing, People’s Republic of China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839); Beijing University of Technology, Faculty of Environment and Life Science, Beijing, People’s Republic of China (GRID:grid.28703.3e) (ISNI:0000 0000 9040 3743) 
 Beijing Institute of Radiation Medicine, Department of Pharmaceutical Sciences, Beijing, People’s Republic of China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839); Guangdong Pharmaceutical University, School of Pharmacy, Guangzhou, People’s Republic of China (GRID:grid.411847.f) (ISNI:0000 0004 1804 4300) 
Pages
1696
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2916553962
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.